Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Coordination Pharmaceuticals, Inc.
Primary Objectives: • To determine the tolerability of RiMO-401 with palliative radiation as assessed by CTCAEv5 Secondary Objectives: * To determine clinical response of RiMO-401 with palliative radiotherapy * To characterize adverse events of RiMO-401 in patients with advanced cancers * To characterize the pharmacokinetics of RiMO-401 with palliative radiation The target population comprises patients with clinically accessible lesions that can be trated with palliative radiation.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted